GB202018227D0
2020-11-19
Treatment
US2021054037A1
2020-09-10
Peptides of page5
US2021093732A1
2020-08-07
Peptides derived from transient receptor potential cation channel subfamily m member 1 (trpm1), complexes comprising such peptides bound to mhc molecules
GB202010329D0
2020-07-06
Specific binding molecules
GB202006629D0
2020-05-05
Specific binding molecules
WO2020148372A1
2020-01-16
Formulations
GB201915282D0
2019-10-22
Specific binding molecules
GB201909509D0
2019-07-02
Peptide-MHC complexes
AU2019270301A1
2019-05-14
Bifunctional binding polypeptides
GB201905105D0
2019-04-10
Formulations
GB201904328D0
2019-03-28
Specific binding molecules
GB201901306D0
2019-01-30
Multi-domain binding molecules
GB201901305D0
2019-01-30
Specific binding molecules
GB201900658D0
2019-01-17
Formulation
GB201820078D0
2018-12-10
T cell receptors
GB201819584D0
2018-11-30
Bifunctional binding polypeptide
GB201807767D0
2018-05-14
Bifunctional binding polypeptide
GB201803750D0
2018-03-08
Method
WO2018083505A1
2017-11-07
Peptides
GB201709866D0
2017-06-20
T cell receptors
